Corvus Pharmaceuticals CRVS Institutional Ownership

NASDAQ CRVS

$10.05 -0.18 (-1.76%)

At close: Oct 21, 2026 · 4:00 PM EDT

Institutions by Trading Activity

174 Institutions

Increased 112 64.4%

Unchanged 22 12.6%

Reduced 40 23.0%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

76.55%

▼-1.20 pp QoQ

Shares Held by Institutions

70.71Mn

of 92.37Mn outstanding

▲+1.05% QoQ

Shares Outstanding

92.37Mn

21.66Mn held outside 13F filers

Institutional Investors

174

filed 13F for Jun 2026

▲+10 vs prior quarter

Net Shares Added (QoQ)

+735.95K

accumulated since last quarter

Value of Holdings

$723.37Mn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Updated Oct 11, 2026

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) appeared in the 13F filings of 174 institutional investors for the quarter ended June 30, 2026.

These investors held 76.55% of outstanding shares in Q2 2026, down from 77.75% the quarter before.
Total shares held in Corvus Pharmaceuticals rose 1.05% versus Q1 2026, while the number of holders rose 93.33% versus Q2 2025.
Of the 174 holders, 112 added to their positions, 40 reduced their stakes and 22 left their positions unchanged in Q2 2026.
Combined, institutional investors held 70.71Mn shares of CRVS as of Q2 2026, up 735.95K from the prior quarter and up 29.84Mn from a year earlier.
OrbiMed Advisors LLC held the largest position in CRVS at 7.17Mn shares as of June 30, 2026, or 7.76% of shares outstanding.
Holders that added the most shares of Corvus Pharmaceuticals in Q2 2026 were BlackRock, Inc. (+978.39K shares), State Street Corp (+908.1K shares), T. Rowe Price Associates Inc (+871.83K shares), Bank of America Corp (+520.79K shares) and Wellington Management Group LLP (+413.12K shares).
On the other side, among holders that kept a position in Corvus Pharmaceuticals, the largest reductions in Q2 2026 came from Morgan Stanley (-1.15Mn shares), Marshall Wace, LLP (-447.81K shares), Squarepoint Ops LLC (-79.69K shares), Citadel Advisors LLC (-44.57K shares) and TD Asset Management Inc (-41.14K shares).
Per Business Quant data, the 10 largest holders of Corvus Pharmaceuticals at the end of Q2 2026 were OrbiMed Advisors LLC (7.17Mn shares), BlackRock, Inc. (7.14Mn shares), State Street Corp (4.47Mn shares), T. Rowe Price Associates Inc (3.79Mn shares), Vanguard Capital Management LLC (3.29Mn shares), Adams Street Partners LLC (3.28Mn shares), Vivo Capital, LLC (2.81Mn shares), Wellington Management Group LLP (2.73Mn shares), Perceptive Advisors LLC (2.67Mn shares) and Deep Track Capital, LP (2.49Mn shares).

Form 13F Holdings

174 Institutional Holders

Report period 30 Jun, 2026

Total shares held 70.71Mn

Of outstanding 76.55%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	ORBIMED ADVISORS LLC	0001055951	7,165,006	7.76%	0	0.00%	$107.05Mn
2	BlackRock, Inc.	0002012383	7,138,811	7.73%	▲978,389	+15.88%	$106.65Mn
3	State Street Corp	0000093751	4,474,091	4.84%	▲908,099	+25.47%	$66.84Mn
4	PRICE T ROWE ASSOCIATES INC /MD/	0000080255	3,789,126	4.10%	▲871,826	+29.88%	$56.61K
5	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	3,292,710	3.56%	▲58,172	+1.80%	$49.19Mn
6	ADAMS STREET PARTNERS LLC	0001193586	3,275,616	3.55%	0	0.00%	$48.94Mn
7	Vivo Capital, LLC	0001674712	2,805,816	3.04%	0	0.00%	$41.92Mn
8	WELLINGTON MANAGEMENT GROUP LLP	0000902219	2,731,632	2.96%	▲413,115	+17.82%	$40.81Mn
9	PERCEPTIVE ADVISORS LLC	0001224962	2,667,441	2.89%	▲375,000	+16.36%	$39.85Mn
10	Deep Track Capital, LP	0001856083	2,491,939	2.70%	▲400	+0.02%	$37.23Mn
11	BRAIDWELL LP	0001920938	2,126,298	2.30%	▲373,500	+21.31%	$31.77Mn
12	GEODE CAPITAL MANAGEMENT, LLC	0001214717	1,853,659	2.01%	▲140,918	+8.23%	$27.70Mn
13	Foresite Capital Management VI LLC	0002013341	1,831,233	1.98%	0	0.00%	$27.36Mn
14	Goldman Sachs Group Inc	0000886982	1,576,352	1.71%	▲35,543	+2.31%	$23.55Mn
15	Hood River Capital Management LLC	0001578177	1,571,805	1.70%	▲236,696	+17.73%	$23.48Mn
16	Morgan Stanley	0000895421	1,344,736	1.46%	▼1,154,089	-46.19%	$20.09Mn
17	Boxer Capital Management, LLC	0002018299	1,100,000	1.19%	0	0.00%	$16.43Mn
18	Catalio Capital Management, LP	0001958125	1,080,888	1.17%	▲188,955	+21.18%	$16.15Mn
19	MILLENNIUM MANAGEMENT LLC	0001273087	1,047,985	1.13%	▲181,623	+20.96%	$15.66Mn
20	VANGUARD PORTFOLIO MANAGEMENT LLC	0002100121	814,750	0.88%	▲144,855	+21.62%	$12.17Mn

Showing 1 to 20 of 174 holders